A case series of serious and unexpected adverse drug reactions under treatment with cariprazine

Reporting of new or unexpected adverse drug reactions of medicines that are subject to additional monitoring (“black triangle” label), such as the antipsychotic drug cariprazine, is of paramount importance to improve pharmacotherapy safety. Reporting of new or unexpected adverse drug reactions of me...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical case reports 2021-05, Vol.9 (5), p.e04084-n/a
Hauptverfasser:	Heck, Johannes, Seifert, Johanna, Stichtenoth, Dirk O., Schroeder, Christoph, Groh, Adrian, Szycik, Gregor R., Degner, Detlef, Adamovic, Ivana, Schneider, Michael, Glocker, Catherine, Rüther, Eckart, Bleich, Stefan, Grohmann, Renate, Toto, Sermin
Format:	Artikel
Sprache:	eng
Schlagworte:	adverse drug reactions Anesthesia cariprazine Case Report Case Reports Dopamine dopamine supersensitivity psychosis Drug dosages drug safety Hospitalization hyperprolactinemia Patient safety Psychosis Psychotropic drugs Schizophrenia Substance abuse treatment
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Reporting of new or unexpected adverse drug reactions of medicines that are subject to additional monitoring (“black triangle” label), such as the antipsychotic drug cariprazine, is of paramount importance to improve pharmacotherapy safety. Reporting of new or unexpected adverse drug reactions of medicines that are subject to additional monitoring (“black triangle” label), such as the antipsychotic drug cariprazine, is of paramount importance to improve pharmacotherapy safety.
ISSN:	2050-0904 2050-0904
DOI:	10.1002/ccr3.4084